Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Jan 23, 2025

Total Value ($000): $529,047 (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 63.2%

Value ($000) $334,383 Shares 19,963,157 Est. Cost $20.88 Unrealized —

NAMS NEWAMSTERDAM PHARMA COMPANY 13.9%

Value ($000) $73,748 Shares 2,869,565 Est. Cost $10.96 Unrealized +93.9%

PHAT PHATHOM PHARMACEUTICALS INC 11.5%

Value ($000) $60,612 Shares 7,464,572 Est. Cost $13.72 Unrealized -9.7%

— RAPT THERAPEUTICS INC 6.7%

Value ($000) $35,316 Shares 22,352,000 Est. Cost $1.58 Unrealized —

AURA AURA BIOSCIENCES INC 4.7%

Value ($000) $24,988 Shares 3,039,892 Est. Cost $17.87 Unrealized -47.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$334,383	63.2%	$20.88	—	SPONSORED ADS	152309100
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,869,565	$73,748	13.9%	$10.96	+93.9%	ORDINARY SHARES	N62509109
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$60,612	11.5%	$13.72	-9.7%	COM	71722W107
—	RAPT THERAPEUTICS INC	22,352,000	$35,316	6.7%	$1.58	—	COM	75382E109
AURA	AURA BIOSCIENCES INC	3,039,892	$24,988	4.7%	$17.87	-47.3%	COM	05153U107